Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
about
Non-communicable diseases in sub-Saharan Africa: the case for cohort studiesPolymorphisms in innate immunity genes and lung cancer risk in Xuanwei, ChinaOmega-3 Polyunsaturated Fatty Acids Intake to Regulate Helicobacter pylori-Associated Gastric Diseases as Nonantimicrobial Dietary ApproachHIV infection, aging, and immune function: implications for cancer risk and preventionBreast cancer chemoprevention: old and new approachesNovel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancerThe role of the hepatitis viruses in cholangiocarcinomaSerum amyloid A: an acute-phase protein involved in tumour pathogenesisSystematic review and meta-analysis on the association between IL-1B polymorphisms and cancer riskPulmonary Inflammation Impacts on CYP1A1-Mediated Respiratory Tract DNA Damage Induced by the Carcinogenic Air Pollutant Benzo[a]pyrenePersistent effects of Libby amphibole and amosite asbestos following subchronic inhalation in ratsAssociation between Subclinical Malaria Infection and Inflammatory Host Response in a Pre-Elimination SettingBronchoalveolar Lavage Fluid Utilized Ex Vivo to Validate In Vivo Findings: Inhibition of Gap Junction Activity in Lung Tumor Promotion is Toll-Like Receptor 4-DependentOccupational exposure to crystalline silica and gastric cancer: a systematic review and meta-analysis.Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.NF-κB signalling and cell fate decisions in response to a short pulse of tumour necrosis factor.Non-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data.Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study.T-cell activation promotes tumorigenesis in inflammation-associated cancer.Bacteria peptidoglycan promoted breast cancer cell invasiveness and adhesiveness by targeting toll-like receptor 2 in the cancer cellsAssociations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle studyNonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health StudyAssociations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammationTranscriptional profiling of the acute pulmonary inflammatory response induced by LPS: role of neutrophils.Non-pulmonary cancer risk following tuberculosis: a nationwide retrospective cohort study in Lithuania.Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model.The mutator phenotype in cancer: molecular mechanisms and targeting strategiesLung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.Urinary PGE-M levels are associated with risk of colorectal adenomas and chemopreventive response to anti-inflammatory drugs.Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8.Immune cells: plastic players along colorectal cancer progressionActivated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.NF-κB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attackTOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinomaTriptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.mPGES-1 expression in non-cancerous liver tissue impacts on postoperative recurrence of HCC.Association of haplotypes of inflammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians.Omega-3 polyunsaturated Fatty acids as potential chemopreventive agent for gastrointestinal cancerC-reactive protein, interleukin 6 and lung cancer risk: a meta-analysisNew insights on cholangiocarcinoma.
P2860
Q21563451-4698CE26-375E-4251-99AF-4BC2ACD67BBBQ24645582-E3ACA26C-B3F3-4815-82A2-1C737A2015F7Q26784466-C304E67E-375F-48EB-84E6-F68292EC2889Q27004165-21F65484-6289-4FA9-A52D-169D45E8BBB1Q27693259-C6A77917-8BFC-4425-B7CD-7D9351AEF524Q28066348-32F882E4-10E4-4A97-96F2-E7AECB0DE92CQ28288613-786FEB7B-0B9B-4A18-A583-AD9EFBCEDC4FQ28291806-7A64FBD8-C694-4C5B-B744-B25C1D2FD792Q28383264-F43B04C8-7AEA-4B3E-B1F6-ACA9A75A3990Q28384530-3BD56D32-55B4-413E-997B-889DB835D660Q28392213-15276361-FB24-4027-9F13-0CB7469B4775Q28596625-34B65B67-C8D5-4EB0-B49A-87C9E77C83DDQ28655716-4E7ED43C-465F-4361-B61E-89D4B8F2075BQ30245402-76CCA771-16EA-410E-B784-82D19FD21876Q30502672-93D7140C-EA07-4526-8534-88A09FD3FF51Q30832764-B97A0C2B-9DE5-44FD-8996-E8F2A19974E5Q33304363-075495F1-72BA-4A64-9B9B-9E3349F9A690Q33509281-4FE1D5C3-0C73-4910-96CF-D27EFF63149AQ33590130-2E08019B-08F2-4D99-8AD8-85E40938792AQ33592943-53E29907-90CD-4082-B8E1-27FFDC6E35FBQ33623296-EF4367A0-FADA-4E58-AF37-0038DC7AA16AQ33645700-CFF70E94-265E-4B17-9342-99486BE2821DQ33724542-9C51EB30-C30F-4DF7-9388-487A2914186EQ33728845-6FC876BD-A77C-4288-BAC1-583412160913Q33750017-5EA4BD66-B014-4F7B-B3C5-FAC8CAB251F6Q33764534-200CCEB4-0163-4284-AD90-148E1DB6A199Q33815796-80A96DD8-7E02-4B4A-85DD-E8B88A4395A1Q33837125-7BFBC9FE-EFAC-4BCF-91F9-09602F5745DEQ33857191-48C0CAD9-CB30-419B-BC44-2521084529F3Q33925759-A2A1CE87-A690-40DA-B86E-2A6ADC87FA15Q33985586-449D0902-F741-42E8-9C5A-981A0F428BE4Q33992208-21373470-B8AB-489A-843E-FC4B32021591Q34039343-3FAF5477-19E8-441B-8D28-965898B05A02Q34044864-789E9CA3-2E95-41D8-8C9B-93B12A2BCD17Q34173719-59F38080-AFA9-4618-9A39-71FE0F01DAC9Q34200876-1EBAE271-FA48-4072-9FE4-C14094307C28Q34242393-A6E96DC1-5453-4570-B76B-35ADDAC4C134Q34305428-A27213FB-BED9-4B74-B8CF-105C9CA35392Q34389236-B65DEFA9-68DA-4F84-878A-8AB906EB44CDQ34391135-4CF3BE2A-F14D-4460-BBE2-407F08C379D5
P2860
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
@ast
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
@en
type
label
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
@ast
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
@en
prefLabel
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
@ast
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
@en
P356
P1433
P1476
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
@en
P2093
David Schottenfeld
Jennifer Beebe-Dimmer
P356
10.3322/CANJCLIN.56.2.69
P407
P577
2006-03-01T00:00:00Z